Kamran Alam
Chief Financial Officer
CFO
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Taysha Gene Therapies, Inc. (TSHA) | Chief Financial Officer | $473,331 | $2,146,964 |
| 2024 | Taysha Gene Therapies, Inc. (TSHA) | Chief Financial Officer | $455,126 | $2,518,777 |
| 2023 | Taysha Gene Therapies, Inc. (TSHA) | Chief Financial Officer | $413,751 | $975,401 |
| 2022 | Taysha Gene Therapies, Inc. (TSHA) | Chief Financial Officer | $401,700 | $1,201,823 |
| 2020 | Rocket Pharmaceuticals, Inc. (RCKT) | Senior Vice President – Finance and Principal Financial Officer | $197,230 | $634,250 |
| 2019 | Rocket Pharmaceuticals, Inc. (RCKT) | Senior Vice President – Finance and Principal Financial Officer | $54,545 | $2,051,457 |
Earnings-call appearances
-
Taysha Gene Therapies, Inc. Q1 FY2025 Earnings Call2025-05-15
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2024 Earnings Call2025-02-26
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2024 Earnings Call2024-11-13
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2024 Earnings Call2024-08-12
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2024 Earnings Call2024-06-26
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2023 Earnings Call2024-03-19
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2023 Earnings Call2023-11-14
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2023 Earnings Call2023-08-14
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2023 Earnings Call2023-05-15
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2022 Earnings Call2023-03-28
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2022 Earnings Call2022-11-08
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2022 Earnings Call2022-08-11
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2022 Earnings Call2022-05-16
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q4 FY2021 Earnings Call2022-03-31
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q3 FY2021 Earnings Call2021-11-10
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q2 FY2021 Earnings Call2021-08-16
Taysha Gene Therapies, Inc. (TSHA)
-
Taysha Gene Therapies, Inc. Q1 FY2021 Earnings Call2021-05-11
Taysha Gene Therapies, Inc. (TSHA)